Shandong Xinhua Pharmaceutical Co Ltd banner

Intrinsic Value

The intrinsic value of Shandong Xinhua Pharmaceutical Co Ltd (XIN) under the Base Case is 0.986 EUR per share. Compared with the current market price of 0.575 EUR, the stock appears Undervalued by 42% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

XIN Intrinsic Value
€0.986
Undervaluation 42%
Intrinsic Value
Price €0.575
Alert me when XIN is below its intrinsic value
Today €0.493 · 14.3% below the current price

XIN is cheaper than usual. It was this cheap or cheaper on just 22% of days in the past 5 years.

Alternatives to XIN

Fundamental Analysis

What Shandong Xinhua Pharmaceutical Does

Pharmaceuticals Health Care

Shandong Xinhua Pharmaceutical makes medicines and pharmaceutical ingredients. It sells finished drugs such as tablets, injections, and other dosage forms, along with active pharmaceutical ingredients and chemical intermediates that drug makers use to produce medicines. Its products serve hospitals, pharmacies, distributors, and other pharmaceutical companies.

Headquarters
China CN
Employees
7 240
IPO date
Dec 31, 1996
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Shandong Xinhua Pharmaceutical Co Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one XIN stock?

The intrinsic value for Shandong Xinhua Pharmaceutical Co Ltd (XIN) under the Base Case is 0.986 EUR.

Is XIN stock undervalued or overvalued?

Compared with the current market price of 0.575 EUR, the stock appears Undervalued by 42% .

Back to Top